RT Journal Article
SR Electronic
T1 Two Color Single Molecule Sequencing on GenoCare™ 1600 Platform to Facilitate Clinical Applications
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.28.20203455
DO 10.1101/2020.09.28.20203455
A1 Chen, Fang
A1 Liu, Bin
A1 Chen, Meirong
A1 Jiang, Zefei
A1 Zhou, Zhiliang
A1 Wu, Ping
A1 Zhang, Meng
A1 Jin, Huan
A1 Li, Linsen
A1 Lu, Liuyan
A1 Wang, Qi
A1 Shang, Huan
A1 Xie, Bing
A1 Liu, Lei
A1 Lin, Xia
A1 Chen, Weiyue
A1 Xu, Jianfeng
A1 Sun, Ruitao
A1 Wang, Guangming
A1 Zheng, Jiao
A1 Qi, Jifang
A1 Yang, Bo
A1 Chen, Dexia
A1 Zeng, Lidong
A1 Li, Gailing
A1 Li, Yan
A1 Lv, Hui
A1 Zhao, Nannan
A1 Zhou, Bo
A1 Wang, Wen
A1 Cai, Jinsen
A1 Liu, Siyu
A1 Luo, Weiwei
A1 Zhang, Juan
A1 Zhang, Yanhua
A1 Lu, Yongyi
A1 Fan, Jicai
A1 Dan, Haitao
A1 He, Xuesen
A1 Liu, Lichun
A1 Feng, Yan
A1 Chen, Jianglin
A1 Huang, Wei
A1 Sun, Lei
A1 Yan, Qin
YR 2020
UL http://medrxiv.org/content/early/2020/09/29/2020.09.28.20203455.abstract
AB With the rapid development of precision medicine industry, DNA sequencing becomes increasingly important as a research and diagnosis tool. For clinical applications, medical professionals require a platform which is fast, easy to use, and presents clear information relevant to definitive diagnosis. We have developed a single molecule desktop sequencing platform, GenoCare™ 1600. Fast library preparation (without amplification) and simple instrument operation make it friendlier for clinical use. Here we presented sequencing data of E. coli sample from GenoCare™ 1600 with consensus accuracy reaches 99.99%. We also demonstrated sequencing of microbial mixtures and COVID-19 samples from throat swabs. Our data show accurate quantitation of microbial, sensitive identification of SARS-CoV-2 virus and detection of variants confirmed by Sanger sequencing.Competing Interest StatementThe authors declare competing financial interests: all authors are employees or contractors that work for GeneMind Biosciences Company Limited.Funding StatementAll authors are employees of GeneMind Biosciences Company Limited. No external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of GeneMind Biosciences Company LimitedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSupplementary material is submitted as "Supplementary Information-Two Color Single Molecule Sequencing on Genocare 1600 Platform to Facilitate Clinical Applications.pdf".